simendan has been researched along with Ventricular Dysfunction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gooi, A; Karl, T; Pandey, R; Ramakrishnan, K | 1 |
| Duman, D; Fotbolcu, H | 1 |
| Carmona Aurioles, J; Delange Segura, L; Jerez Anera, M; Rodríguez Fernández, S | 1 |
| Domínguez Rodríguez, A; García González, MJ | 1 |
| Butt, WW; Crossland, DS; Namachivayam, P; Shekerdemian, LS | 1 |
| Arribas López, P; Corres Peiretti, MA; Gutiérrez Rodríguez, J; Hernández Tejedor, A; Perales Rodríguez De Viguri, N; Pérez Vela, JL; Renes Carreño, E; Rubio Regidor, M | 1 |
2 review(s) available for simendan and Ventricular Dysfunction
| Article | Year |
|---|---|
A promising new inotrope: levosimendan.
Topics: Calcium; Cardiac Output; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Potassium Channels; Pyridazines; Simendan; Treatment Outcome; Ventricular Dysfunction | 2010 |
Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
Topics: Adenosine Triphosphate; Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Models, Biological; Myocardial Stunning; Potassium Channels; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Ventricular Dysfunction | 2006 |
4 other study(ies) available for simendan and Ventricular Dysfunction
| Article | Year |
|---|---|
Use of β-blockade and levosimendan for separation from extracorporeal life support in an infant with postoperative diastolic dysfunction.
Topics: Adrenergic beta-Antagonists; Aortic Valve Stenosis; Cardiotonic Agents; Diastole; Drug Therapy, Combination; Extracorporeal Circulation; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Hydrazones; Infant, Newborn; Male; Postoperative Complications; Pyridazines; Simendan; Ventricular Dysfunction; Ventricular Outflow Obstruction | 2013 |
[Levosimendan as inotropic support during coronary surgery with extracorporeal circulation in a patient with severely depressed ventricular function].
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Coronary Stenosis; Extracorporeal Circulation; Heart Ventricles; Humans; Hydrazones; Male; Pyridazines; Reoperation; Simendan; Stents; Ventricular Dysfunction | 2003 |
Early experience with Levosimendan in children with ventricular dysfunction.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Catecholamines; Child; Child, Preschool; Cohort Studies; Critical Illness; Humans; Hydrazones; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Pyridazines; Retrospective Studies; Simendan; Stroke Volume; Ultrasonography; Ventricular Dysfunction | 2006 |
[Levosimendan for postoperative ventricular dysfunction following heart transplantation].
Topics: Adult; Female; Heart Transplantation; Humans; Hydrazones; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Vasodilator Agents; Ventricular Dysfunction | 2008 |